Research Study for the Investigational Use of XEOMIN to treat Blepharospasm (an FDA approved alternative to BOTOX)

Blepharospasm, a condition of uncontrolled blinking of the eyelids, had been traditionally treated with BOTOX.  There is now a new product called XEOMIN that is also FDA approved for treatment of this condition.  Our experience is that XEOMIN is an excellent alternative to BOTOX.  We are now conducting an observational research study that will help us to further determine patient satisfaction with this product.  Patients who are candidates for this procedure will be invited to enter the study and will be compensated for completing the questionnaires.